VA
MRNS

VR Adviser’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

VR Adviser’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,770,705
Closed -$7.05M – 30
2022
Q4 		$7.05M Sell
1,770,705
-1,386,098
-44% -$6.81M 1.19% 21
2022
Q3 		$21M Hold
3,156,803
– – 3.24% 10
2022
Q2 		$15.3M Hold
3,156,803
– – 3.01% 11
2022
Q1 		$29.5M Buy
3,156,803
+276,707
+10% +$2.75M 4.78% 8
2021
Q4 		$34.2M Buy
2,880,096
+238,287
+9% +$2.75M 4.68% 8
2021
Q3 		$30.1M Hold
2,641,809
– – 3.86% 12
2021
Q2 		$47.4M Hold
2,641,809
– – 5.75% 5
2021
Q1 		$40.9M Buy
2,641,809
+52,868
+2% +$765K 4.44% 9
2020
Q4 		$31.6M Buy
2,588,941
+1,396,058
+117% +$19.5M 4.64% 8
2020
Q3 		$15.3M Sell
1,192,883
-238,752
-17% -$2.06M 3% 12
2020
Q2 		$14.5M Sell
1,431,635
-194,075
-12% -$1.79M 3.48% 9
2020
Q1 		$13.2M Buy
+1,625,710
New +$14.1M 3.58% 9

Other funds holding MRNS

SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return